Celldex Therapeutics Inc. (CLDX)
NASDAQ · Healthcare
Celldex Therapeutics Inc. Cash on Hand 2020–2025
Celldex Therapeutics Inc. annual cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Celldex Therapeutics Inc. cash on hand as of December 31, 2025: 28.9M, a 1.82% increase year-over-year.
- Celldex Therapeutics Inc. cash on hand for 2025 were 28.9M, a 1.82% increase from 2024.
- Celldex Therapeutics Inc. cash on hand for 2024 were 28.4M, a 18.55% decrease from 2023.
- Celldex Therapeutics Inc. cash on hand for 2023 were 34.8M, a 18.30% increase from 2022.
- Celldex Therapeutics Inc. cash on hand for 2022 were 29.4M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Celldex Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $29 |
| 2024 | $28 |
| 2023 | $35 |
| 2022 | $29 |
| 2021 | $39 |
| 2020 | $44 |
Celldex Therapeutics Inc. Cash on Hand — FAQ
Celldex Therapeutics Inc. (CLDX) cash on hand over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CLDX's cash on hand history?
The chart and table above show Celldex Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.